• Molecular NameTalinolol
  • SynonymNA
  • Weight363.502
  • Drugbank_IDN/A
  • ACS_NO38649-73-9
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)3.09
  • pkaN/A
  • LogD (pH=7, predicted)0.62
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.34
  • LogSw (predicted, AB/LogsW2.0)1.1
  • Sw (mg/ml) (predicted, ACD/Labs)0.08
  • No.of HBond Donors4
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds8
  • TPSA82.62
  • StatusN/A
  • AdministrationN/A
  • PharmacologyAn beta blocker.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability54.0
  • Protein bindingN/A
  • Volume of distribution (VD)3.3 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmThe main metabolic pathway of talinolol is the hydroxylation of the cyclohexyl ring
  • Half life7.3~18.2 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)LD50=30 mg/kg (intravenous)
  • LD50 (mouse)LD50=593; LD50=38 mg/kg (intravenous)